ASCO Education
Un pódcast de American Society of Clinical Oncology (ASCO)
191 Episodo
-
Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)
Publicado: 27/6/2018 -
Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma
Publicado: 20/6/2018 -
ASCO Guideline: Fertility Preservation in Patients with Cancer
Publicado: 13/6/2018 -
Self-Evaluation: EGFR Mutation
Publicado: 6/6/2018 -
Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer
Publicado: 30/5/2018 -
ASCO Guidelines: Outpatient Management of Fever and Neutropenia
Publicado: 23/5/2018 -
Self-Evaluation: NSCLC Treatment Metastatic
Publicado: 16/5/2018 -
Adjuvant Treatment in Melanoma: Recent Advances
Publicado: 9/5/2018 -
Recently Approved Drugs: Blinatumomab for B-cell precursor ALL
Publicado: 2/5/2018 -
Guidelines: Management of Immune-Related Adverse Events
Publicado: 25/4/2018 -
Treatment Effects & Transition to Survivorship for AYA Patients
Publicado: 18/4/2018 -
EHR Chemotherapy Error: Breast Cancer
Publicado: 11/4/2018 -
Continuity of Care for AYAs
Publicado: 4/4/2018 -
Self-Evaluation: Clinical Trials Informed Consent Process
Publicado: 28/3/2018 -
Self-Evaluation: Clinical Trials
Publicado: 14/3/2018 -
Self-Evaluation: NSCLC
Publicado: 14/2/2018 -
Self-Evaluation: Breast Cancer
Publicado: 7/2/2018 -
Self-Evaluation: Metastatic Breast Cancer
Publicado: 13/12/2017 -
ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update
Publicado: 6/12/2017 -
Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer
Publicado: 22/11/2017
ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book. Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.
